Carlos Henrique de Paula Diniz

CV Lattes ORCID

Secretaria de Desenvolvimento Econômico (São Paulo - Estado). Faculdade de Medicina de São José do Rio Preto (FAMERP) (Institutional affiliation from the last research proposal)
Birthplace: Brazil

Doctor of Medicine (MD) degree from Faculdade de Medicina de São José do Rio Preto, FAMERP (2019-2024). Scientific initiation fellowship grant by Fundação de Amparo à Pesquisa do Estado de São Paulo, FAPESP (2021-2022). Author of review article: "Cetuximab chemotherapy resistance: Insight into the homeostatic evolution of head and neck cancer (Review)" published in Oncology Reports (2024). (Source: Lattes Curriculum)

News published in Agência FAPESP Newsletter about the researcher

More items Less items

TITULO

Articles published in other media outlets ( ):

More items Less items

VEICULO: TITULO (DATA)

Scholarships in Brazil

Completed (most recent)

Abstract
Chemotherapeutic drugs are used to prevent the growth and spread of cancer cells. However, they induce an extreme selective pressure that may result in the selection of resistant subclones. Drug resistance is the biggest problem in cancer therapy today. However, resistance to one drug may come at a cost of increased sensitivity to another drug. This evolutionary process, named collateral …
Epithelial-mesenchymal transition and metabolic homeostasis markers associated with resistance to chemotherapy drug cetuximab and collateral sensitivity to piplartine in head and neck Carcinoma, BP.IC

Virtual Library in numbers * Updated data on August 09, 2025

Total / Available in English

1 / 1	Completed scholarships in Brazil

Associated processes

Most frequent collaborators in research granted by FAPESP

Eloiza Helena Tajara da Silva

Keywords used by the researcher

Health Sciences Medicine

Please report errors on the page using this form.

Short URL

Abstract